494 related articles for article (PubMed ID: 12103431)
1. The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo.
Ives JA; Carr JA; Mendel DB; Tai CY; Lambkin R; Kelly L; Oxford JS; Hayden FG; Roberts NA
Antiviral Res; 2002 Aug; 55(2):307-17. PubMed ID: 12103431
[TBL] [Abstract][Full Text] [Related]
2. Influenza virus carrying neuraminidase with reduced sensitivity to oseltamivir carboxylate has altered properties in vitro and is compromised for infectivity and replicative ability in vivo.
Carr J; Ives J; Kelly L; Lambkin R; Oxford J; Mendel D; Tai L; Roberts N
Antiviral Res; 2002 May; 54(2):79-88. PubMed ID: 12062393
[TBL] [Abstract][Full Text] [Related]
3. Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets.
Herlocher ML; Truscon R; Elias S; Yen HL; Roberts NA; Ohmit SE; Monto AS
J Infect Dis; 2004 Nov; 190(9):1627-30. PubMed ID: 15478068
[TBL] [Abstract][Full Text] [Related]
4. In vitro selection and characterization of influenza A (A/N9) virus variants resistant to a novel neuraminidase inhibitor, A-315675.
Molla A; Kati W; Carrick R; Steffy K; Shi Y; Montgomery D; Gusick N; Stoll VS; Stewart KD; Ng TI; Maring C; Kempf DJ; Kohlbrenner W
J Virol; 2002 Jun; 76(11):5380-6. PubMed ID: 11991966
[TBL] [Abstract][Full Text] [Related]
5. Characterization of oseltamivir-resistant 2009 H1N1 pandemic influenza A viruses.
Kiso M; Shinya K; Shimojima M; Takano R; Takahashi K; Katsura H; Kakugawa S; Le MT; Yamashita M; Furuta Y; Ozawa M; Kawaoka Y
PLoS Pathog; 2010 Aug; 6(8):e1001079. PubMed ID: 20865125
[TBL] [Abstract][Full Text] [Related]
6. Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo.
Yen HL; Ilyushina NA; Salomon R; Hoffmann E; Webster RG; Govorkova EA
J Virol; 2007 Nov; 81(22):12418-26. PubMed ID: 17855542
[TBL] [Abstract][Full Text] [Related]
7. The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses.
Leneva IA; Roberts N; Govorkova EA; Goloubeva OG; Webster RG
Antiviral Res; 2000 Nov; 48(2):101-15. PubMed ID: 11114412
[TBL] [Abstract][Full Text] [Related]
8. Morbidity and mortality associated with nosocomial transmission of oseltamivir-resistant influenza A(H1N1) virus.
Gooskens J; Jonges M; Claas EC; Meijer A; van den Broek PJ; Kroes AM
JAMA; 2009 Mar; 301(10):1042-6. PubMed ID: 19255111
[TBL] [Abstract][Full Text] [Related]
9. Effect of the neuraminidase mutation H274Y conferring resistance to oseltamivir on the replicative capacity and virulence of old and recent human influenza A(H1N1) viruses.
Baz M; Abed Y; Simon P; Hamelin ME; Boivin G
J Infect Dis; 2010 Mar; 201(5):740-5. PubMed ID: 20100088
[TBL] [Abstract][Full Text] [Related]
10. Effect of an asparagine-to-serine mutation at position 294 in neuraminidase on the pathogenicity of highly pathogenic H5N1 influenza A virus.
Kiso M; Ozawa M; Le MT; Imai H; Takahashi K; Kakugawa S; Noda T; Horimoto T; Kawaoka Y
J Virol; 2011 May; 85(10):4667-72. PubMed ID: 21367898
[TBL] [Abstract][Full Text] [Related]
11. A conformational restriction in the influenza A virus neuraminidase binding site by R152 results in a combinational effect of I222T and H274Y on oseltamivir resistance.
Huang L; Cao Y; Zhou J; Qin K; Zhu W; Zhu Y; Yang L; Wang D; Wei H; Shu Y
Antimicrob Agents Chemother; 2014; 58(3):1639-45. PubMed ID: 24366752
[TBL] [Abstract][Full Text] [Related]
12. Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.
Kawai N; Ikematsu H; Hirotsu N; Maeda T; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Matsuura S; Nishimura M; Iwaki N; Kashiwagi S
Clin Infect Dis; 2009 Dec; 49(12):1828-35. PubMed ID: 19911968
[TBL] [Abstract][Full Text] [Related]
13. Resistant influenza A viruses in children treated with oseltamivir: descriptive study.
Kiso M; Mitamura K; Sakai-Tagawa Y; Shiraishi K; Kawakami C; Kimura K; Hayden FG; Sugaya N; Kawaoka Y
Lancet; 2004 Aug 28-Sep 3; 364(9436):759-65. PubMed ID: 15337401
[TBL] [Abstract][Full Text] [Related]
14. An oseltamivir-resistant avian H1N1 influenza A virus can transmit from mallards to chickens similarly to a wild-type strain: implications for the risk of resistance transmission to humans.
Skog E; Nykvist M; Naguib MM; Wille M; Bröjer C; Agarwal V; Ellström P; Westman G; Lundkvist Å; Järhult JD
J Gen Virol; 2023 Apr; 104(4):. PubMed ID: 37018118
[TBL] [Abstract][Full Text] [Related]
15. Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season.
Baranovich T; Saito R; Suzuki Y; Zaraket H; Dapat C; Caperig-Dapat I; Oguma T; Shabana II; Saito T; Suzuki H;
J Clin Virol; 2010 Jan; 47(1):23-8. PubMed ID: 19962344
[TBL] [Abstract][Full Text] [Related]
16. Characterization of an influenza A (H3N2) virus resistant to the cyclopentane neuraminidase inhibitor RWJ-270201.
Smee DF; Sidwell RW; Morrison AC; Bailey KW; Baum EZ; Ly L; Wagaman PC
Antiviral Res; 2001 Dec; 52(3):251-9. PubMed ID: 11675142
[TBL] [Abstract][Full Text] [Related]
17. Neuraminidase Mutations Conferring Resistance to Oseltamivir in Influenza A(H7N9) Viruses.
Marjuki H; Mishin VP; Chesnokov AP; De La Cruz JA; Davis CT; Villanueva JM; Fry AM; Gubareva LV
J Virol; 2015 May; 89(10):5419-26. PubMed ID: 25740997
[TBL] [Abstract][Full Text] [Related]
18. Competitive fitness of oseltamivir-sensitive and -resistant highly pathogenic H5N1 influenza viruses in a ferret model.
Govorkova EA; Ilyushina NA; Marathe BM; McClaren JL; Webster RG
J Virol; 2010 Aug; 84(16):8042-50. PubMed ID: 20519385
[TBL] [Abstract][Full Text] [Related]
19. Increased virulence of neuraminidase inhibitor-resistant pandemic H1N1 virus in mice: potential emergence of drug-resistant and virulent variants.
Song MS; Hee Baek Y; Kim EH; Park SJ; Kim S; Lim GJ; Kwon HI; Pascua PN; Decano AG; Lee BJ; Kim YI; Webby RJ; Choi YK
Virulence; 2013 Aug; 4(6):489-93. PubMed ID: 23924955
[TBL] [Abstract][Full Text] [Related]
20. A reverse genetics study of resistance to neuraminidase inhibitors in an influenza A/H1N1 virus.
Abed Y; Goyette N; Boivin G
Antivir Ther; 2004 Aug; 9(4):577-81. PubMed ID: 15456089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
